Randomized Double-blind Placebo Controlled Trial of Intradetrusor Injections of Botox for the Treatment of Refractory Overactive Bladder Secondary to Benign Prostatic Obstruction-BTX0621.
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Benign prostatic hyperplasia; Overactive bladder
- Focus Therapeutic Use
- 24 May 2012 Results from 1 of 2 trial centres presented at the 107th Annual Meeting of the American Urological Association.
- 20 Oct 2010 New trial record